Connect with us

Hi, what are you looking for?

World

AstraZeneca could have COVID-19 vaccine against variant by end-2021: Austrian media

A modified version of AstraZeneca’s COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday.

For the latest headlines, follow our Google News channel online or via the app.

Sarah Walters, AstraZeneca’s Austria country manager, told the Kurier newspaper that studies, so far, indicating the existing AstraZeneca vaccine was less effective against the more infectious variant first documented in South Africa were “too small to draw final conclusions”.

“In the meantime, AstraZeneca and Oxford University have started on modifications to the vaccine for the South African variant and we expect it will be ready by the end of the year, should it be needed,” Walters told the Kurier.

Walters blamed challenges – including delivery delays for the AstraZeneca shot in the European Union – on the “complex process” of producing a vaccine, coupled with the extremely high demand arising from the coronavirus pandemic.

“We had to work without keeping a supply in reserve. As a result, we couldn’t make up for unexpected events,” she said. “We are confident that we will fulfill our commitment to deliver 300 million doses to the European Union this year.”

The Kurier interview did not directly address ongoing investigations into health concerns over the AstraZeneca shot. The EU has put a warning label on the vaccine over its possible linkage to extremely rare blood clots, Denmark has completely halted use of the vaccine and Britain has advised people under 30 to get another brand of vaccine.

Asked about “thousands” of people in Austria who are canceling their appointments for AstraZeneca shots, Walters said the company’s plan was “to continue to transparently provide information about efficacy and safety to doctors, so that they can adequately inform people” of benefits and risks.

British and European Union medicine regulators have said that the overall benefits of using the vaccine outweigh any risks of rare clotting.

Next articles

UAE reports 1,930 COVID-19 cases, four deaths

Gaza Strip records highest-ever daily COVID-19 deaths

Dubai closes 53 food outlets in Quarter 1 of 2021: Municipality

 

 

You May Also Like

World

Sitting by herself at the funeral of Prince Philip on Saturday, Queen Elizabeth cut a regal, but solitary figure: still the monarch, but now...

World

Germany’s vaccine commission, known as STIKO, recommended on Thursday that people under 60-years old who have had a first shot of AstraZeneca’s COVID-19 vaccine...

Energy

United Arab Emirates power producer Abu Dhabi National Energy Co. (TAQA) announced on Wednesday plans to increase its renewable energyassets, in a shift away...

World

Activists opposed to Myanmar’s junta called on Monday for people to stop paying electricity bills and agricultural loans, and keep their children away from...

Advertisement

error: